Device / Technology News

RSS

JAD honors Norwegian scientist with 2012 Alzheimer Award

Anders L-nneborg, PhD, has been chosen as the recipient of the 2012 Alzheimer Award presented by the Journal of Alzheimer's Disease in recognition of his outstanding work on the detection of early Alzheimer's disease.

3 May 2012

JS Genetics announces availability of XCAT-KS buccal swab test

JS Genetics announces the availability of XCAT-KS, its proprietary buccal swab test for the diagnosis of Klinefelter syndrome (KS) and other male sex chromosome aneuploidies.

3 May 2012

Bladder tests performed on women before SUI surgery may not be necessary

Invasive and costly tests commonly performed on women before surgery for stress urinary incontinence (SUI) may not be necessary, according to researchers at the University of California San Diego, School of Medicine and the Urinary Incontinence Treatment Network. The study, supported by the National Institutes of Health (NIH), will be released online May 2 by the New England Journal of Medicine.

3 May 2012

Patients with spinal cord injury report higher rates of wheelchair breakdowns

Wheelchair-dependent patients with spinal cord injury (SCI) are reporting higher rates of wheelchair breakdowns requiring repairs, according to a study in American Journal of Physical Medicine & Rehabilitation (AJPM&R), the official journal of the Association of Academic Physiatrists, AJPM&R is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 May 2012

Enrollment complete in Hanger’s WalkAide System clinical trial for stroke

Hanger Orthopedic Group, Inc. today announced the completion of enrollment in its pivotal INSTRIDE investigational device exemption (IDE) clinical trial studying the effectiveness of its WalkAide System in the rehabilitation of stroke survivors.

3 May 2012

EKOS launches two landmark clinical studies on pulmonary embolism

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

3 May 2012

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

Xcellerex, Inc., a provider of turnkey biomanufacturing solutions, has launched its XDUO Quad single-use mixing system supporting single-use biomanufacturing in upstream and downstream mixing applications and unit operations.

3 May 2012

FDA clears Angioslide’s new 3X100mm PROTEUS device

Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature.

3 May 2012

Levetiracetam to be tested for seizure management in malaria endemic regions

Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral malaria but are left stricken with epilepsy or other neurologic disorders.

2 May 2012

Online assessment tool for stroke

Nearly 800,000 Americans will suffer a stroke this year, yet most people in the U.S. cannot identify stroke warning signs or risk factors. HealthONE Stroke Care hopes to change that during May's National Stroke Awareness Month with the introduction of its new Stroke Risk Profiler, an online assessment tool for adults of all ages

2 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

Nanocomposite dental cavity-filling kills harmful bacteria

Scientists using nanotechology at the University of Maryland School of Dentistry have created the first cavity-filling composite that kills harmful bacteria and regenerates tooth structure lost to bacterial decay.

2 May 2012

FDA permits Percutaneous Surgical Set for minimally invasive laparoscopic abdominal surgery

On April 30, the U.S. Food and Drug Administration today allowed marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery.

2 May 2012

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

Viora is excited to announce that its popular "Rent-to-Own" program for Reaction™ will now be offered in Canada to medical aesthetic practitioners. Now Canadian physicians will have the ability to introduce the leading medical aesthetic device for body contouring and skin tightening into their practice at minimal risk - with no capital investment, no financing, and no long term commitment.

2 May 2012

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.

From Novo Nordisk 2 May 2012

Genalyte to highlight Maverick Detection System at immunology conferences

Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced that it will launch an Early Access program for its Maverick™ Detection System and multiplexed autoimmune assays at two major immunology meetings in May.

2 May 2012

Cell-based test to discover molecules for treatment of ER-positive breast cancer

Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.

2 May 2012

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

2 May 2012

Accelerated partial breast irradiation therapy increases risk for subsequent mastectomy

Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.

2 May 2012

Almac acquires high-speed blister line for new Audubon packaging facility

Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, is pleased to announce the acquisition of a state-of-the-art, high-speed blister line for their new 100,000ft2 US commercial packaging facility in Audubon, PA.

2 May 2012